[Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
To evaluate the efficacy of finasteride in the treatment of prostatic origin haematuria. This is a prospective observational study in 29 patients with hematuria from a demonstrated prostatic-origin which were treated with finasteride 5 mg/day. 58.6% had undergone previous prostatic surgery. Both previous-to-treatment hematuria and response to treatment were evaluated under the Puchner & Miller's criteria. Response rate was 86.2% without additional haematuria episodes. The remaining patients had mild haematuria episodes during follow-up. No patient needed surgery. Finasteride is effective in the treatment of prostatic-origin haematuria.